Sequential analysis of censored survival data from three treatment groups

Biometrics

Volumn 53, Issue 3, 1997, Pages 807-822

  Betensky, Rebecca A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

O'Brien Fleming test; Repeated significance test; Sequential test

Indexed keywords

O'BRIEN; O'BRIEN-FLEMING TEST; REPEATED SIGNIFICANCE TEST; SEQUENTIAL ANALYSIS; SEQUENTIAL TESTS; SIGNIFICANCE TEST; SIMPLE++; SURVIVAL DATA; TIME-SCALES; TREATMENT GROUP;

ARTICLE; CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SEQUENTIAL ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0030817623     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533544     Document Type: Article

References (19)

1. Armitage, P., McPherson, C. K., and Rowe, B. C. (1969). Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A 132, 235-244.
2. Betensky, R. A. (1996). An O'Brien-Flemming sequential trial for comparing three treatments. Annals of Statistics 24, 1765-1791.
3. Carlson, R. W., Sikic, B. I., Hendrickson, C. G., Schiff, S. A., Deisseroth, A. B., Harrison, D. T., Ahn, D. K., Acord, P. A., and Gandara, D. R. (1990). Superiority of 9 versus 7 drug alternating chemotherapy in extensive stage small cell lung cancer (SCLC): The Northern California Oncology Group (NCOG) trial. Proceedings of the American Society of Clinical Oncology 9, 225.
4. Christensen, R. (1987). Plane Answers to Complex Questions. New York: Springer-Verlag.
5. DeMets, D. L. and Gail, M. H. (1985). Use of logrank tests and group sequential methods at fixed calendar times. Biometrics 41, 1039-1044.
6. Follmann, D. A., Proschan, M. A., and Geller, N. L. (1994). Monitoring pairwise comparisons in multi-armed clinical trials. Biometrics 50, 325-336.
7. Gu, M. and Ying, Z. (1995). Group sequential methods for survival data using partial likelihood score processes with covariate adjustment. Statistica Sinica 5, 793-804.
8. 2 and F tests. Biometrika 78, 133-141.
9. Lan, K. K. G. and DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika 70, 659-663.
10. Miller, R. G., Jr. (1981). Survival Analysis. New York: Wiley.
11. O'Brien, P. C. and Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics 35, 549-556.
12. Pocock, S. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika 64, 191-200.
13. Sellke, T. and Siegmund, D. (1983). Sequential analysis of the proportional hazards model. Biometrika 70, 315-326.
14. Siegmund, D. (1993). A sequential clinical trial for comparing three treatments. Annals of Statistics 21, 464-483.
15. Slud, E. V. (1994). Analysis of factorial survival experiments. Biometrics 50, 25-38.
16. Tsiatis, A. (1981). The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time. Biometrika 68, 311-315.
17. Tsiatis, A. (1982). Repeated significance testing for a general class of statistics used in censored survival analysis. Journal of the American Statistical Association 77, 855-861.
18. Tsiatis, A., Boucher, H., and Kim, K. (1995). Sequential methods for parametric survival models Biometrika 82, 165-174.
19. Wang, S. K. and Tsiatis, A. A. (1987). Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 43, 193-199.